FDA NDC Directory · JSON-LD · Markdown

Imlygic

NDC 55513-079 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic nametalimogene laherparepvec
Labeler / ManufacturerAmgen Inc
Marketing categoryBiologic License Application · App BLA125518
Dosage form / routeINJECTION, SUSPENSION · INTRALESIONAL
Active ingredientsTALIMOGENE LAHERPAREPVEC (100000000 [PFU]/mL)
Marketing started20151102
Package count1

External sources

Source: openFDA. Public-domain (CC0).